H02 Stock Overview
Manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Haw Par Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$10.98 |
| 52 Week High | S$11.52 |
| 52 Week Low | S$9.44 |
| Beta | 0.38 |
| 1 Month Change | -1.79% |
| 3 Month Change | 0.64% |
| 1 Year Change | 15.09% |
| 3 Year Change | -2.75% |
| 5 Year Change | -13.68% |
| Change since IPO | 416.96% |
Recent News & Updates
Investors Holding Back On Haw Par Corporation Limited (SGX:H02)
Dec 19
Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks
Sep 08Recent updates
Investors Holding Back On Haw Par Corporation Limited (SGX:H02)
Dec 19Haw Par Corporation Limited (SGX:H02) Might Not Be As Mispriced As It Looks
Sep 08Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20
Apr 25We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Haw Par Corporation Limited's (SGX:H02) CEO For Now
Apr 16Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.20
Apr 02Haw Par (SGX:H02) Is Increasing Its Dividend To SGD0.20
Aug 14Haw Par (SGX:H02) Could Easily Take On More Debt
Jun 17Haw Par (SGX:H02) Has Announced A Dividend Of SGD0.15
Apr 04Haw Par (SGX:H02) Has A Rock Solid Balance Sheet
Oct 20Haw Par (SGX:H02) Will Pay A Dividend Of SGD0.15
Aug 12Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15
Apr 28Haw Par (SGX:H02) Is Due To Pay A Dividend Of S$0.15
Apr 06Haw Par (SGX:H02) Has Affirmed Its Dividend Of S$0.15
Feb 27Haw Par (SGX:H02) Will Pay A Dividend Of S$0.15
Aug 23Is Haw Par Corporation Limited (SGX:H02) Popular Amongst Institutions?
Jan 24
Should Haw Par Corporation Limited (SGX:H02) Be Part Of Your Dividend Portfolio?
Jan 03Haw Par Corporation Limited (SGX:H02) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Dec 13Shareholders Of Haw Par (SGX:H02) Must Be Happy With Their 50% Return
Nov 23Shareholder Returns
| H02 | SG Pharmaceuticals | SG Market | |
|---|---|---|---|
| 7D | -4.2% | -0.8% | -2.1% |
| 1Y | 15.1% | 9.2% | 12.3% |
Return vs Industry: H02 exceeded the SG Pharmaceuticals industry which returned 9.2% over the past year.
Return vs Market: H02 exceeded the SG Market which returned 12.3% over the past year.
Price Volatility
| H02 volatility | |
|---|---|
| H02 Average Weekly Movement | 1.6% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in SG Market | 13.5% |
| 10% least volatile stocks in SG Market | 1.9% |
Stable Share Price: H02 has not had significant price volatility in the past 3 months compared to the SG market.
Volatility Over Time: H02's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | Ee Lim Wee | www.hawpar.com |
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities.
Haw Par Corporation Limited Fundamentals Summary
| H02 fundamental statistics | |
|---|---|
| Market cap | S$2.43b |
| Earnings (TTM) | S$234.43m |
| Revenue (TTM) | S$239.06m |
10.4x
P/E Ratio10.2x
P/S RatioIs H02 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| H02 income statement (TTM) | |
|---|---|
| Revenue | S$239.06m |
| Cost of Revenue | S$102.66m |
| Gross Profit | S$136.40m |
| Other Expenses | -S$98.03m |
| Earnings | S$234.43m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.06 |
| Gross Margin | 57.06% |
| Net Profit Margin | 98.06% |
| Debt/Equity Ratio | 1.0% |
How did H02 perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield38%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 21:18 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Haw Par Corporation Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ramachandra Kamath | Virtua Research Inc. |